Studies of bone marrow stromal cells (MSCs) transplanted into the spinal cord-injured rat give mixed results: some groups report improved locomotor recovery while others only demonstrate improved histological appearance of the lesion. These studies show no clear correlation between neurological improvements and MSC survival. We examined whether MSC survival in the injured spinal cord could be enhanced by closely matching donor and recipient mice for genetic background and marker gene expression and whether exposure of MSCs to a neural environment (Schwann cells) prior to transplantation would improve their survival or therapeutic effects. Mice underwent a clip compression spinal cord injury at the fourth thoracic level and cell transplantation 7 days later. Despite genetic matching of donors and recipients, MSC survival in the injured spinal cord was very poor (ϳ1%). However, we noted improved locomotor recovery accompanied by improved histopathological appearance of the lesion in mice receiving MSC grafts. These mice had more white and gray matter sparing, laminin expression, Schwann cell infiltration, and preservation of neurofilament and 5-HT-positive fibers at and below the lesion. There was also decreased collagen and chondroitin sulphate proteoglycan deposition in the scar and macrophage activation in mice that received the MSC grafts. The Schwann cell cocultured MSCs had greater effects than untreated MSCs on all these indices of recovery. Analyses of chemokine and cytokine expression revealed that MSC/Schwann cell cocultures produced far less MCP-1 and IL-6 than MSCs or Schwann cells cultured alone. Thus, transplanted MSCs may improve recovery in spinal cord-injured mice through immunosuppressive effects that can be enhanced by a Schwann cell coculturing step. These results indicate that the temporary presence of MSCs in the injured cord is sufficient to alter the cascade of pathological events that normally occurs after spinal cord injury, generating a microenvironment that favors improved recovery.
INTRODUCTION
elucidated for MSC transplantation nor has long-term survival or the fate of transplanted cells been adequately described (17, 52) . Studies of MSC transplantation in Stem cell transplantation has been proposed to be a promising treatment for spinal cord injury (SCI). Theo-spinal cord-injured animals have also had difficulty demonstrating graft survival or mechanisms of action retically, transplanted cells may contribute to repair after SCI by replacing lost neurons or glia or by producing (50) . Some of these studies show successful long-term engraftment of transplanted MSCs into the injured spinal factors that alter the injury site so as to enhance recovery and regeneration. Bone marrow, as a readily accessible cord (1,8, [34] [35] [36] 54, 58, 59) while others report that transplanted MSCs fail to engraft in significant numbers (less source of both somatic stem cells, is an ideal source of donor cells for transplantation after SCI. In spinal cord-than a few percent of transplanted cells surviving >2 weeks) (9, 24, 25, 40, 41, 46, 56) . A portion of the studies injured patients transplanted bone marrow-derived stem cells (MSCs) have been reported to be safe and poten-report improvements in locomotor function after MSC transplantation (8, 9, 24, 25, 34, 41, 54, 56, 58) whereas oth-tially therapeutic (17) . However, in spinal cord-injured patients as well as in patients with other neurodegenera-ers do not (1, 36, 46) . Interestingly, MSC survival in the spinal lesion does not appear to be necessary (41,56) tive diseases clear mechanisms of action have not been or sufficient (1,36) for improved locomotor outcomes. separate from MSC cultures for 4-5 weeks at which time the cells were collected and counted with a hemo-However, even when improved locomotor recovery cannot be demonstrated, elements of the histopathological cytometer. C57B6 mice were used as the source for the Schwann cells in the coculture experiments so that the appearance of the lesion improve as shown by increased tissue sparing, altered extracellular matrix, and increased EGFP-expressing MSCs could eventually be separated from the Schwann cells in these cultures by fluores-axonal growth at the injury site (1, 3536, 46) .
The emerging consensus appears to be that MSC cence-activated cell sorting (FACSvantage SE with Diva Option, BD Bioscience) based on EGFP expression in transplantation may improve neurological outcomes and/or histopathological features of the lesion after SCI. order to transplant SMSCs without contaminating Schwann cells. A 1:1 ratio of MSCs and Schwann cells However fundamental questions regarding the importance of graft survival, differentiation, and mechanisms was mixed in MSC culture medium and 5 × 10 5 total cells were plated into T-75-cm 2 flasks (BD Biosciences, of action still remain unanswered. Several studies using inbred rat strains (25) or immunosuppressants (40, 41) Franklin Lakes, NJ), or 5,000 cells onto a coverglass in 12-well plates. MSCs were cocultured with Schwann failed to show good graft survival. This may reflect insufficient immunosuppression or, where inbred rat strains cells for 1-10 days with medium changes every 48 h. EGFP + MSCs were immune stained with antibodies were used (25), that GFP expressed by donor cells may have been immunogenic (21) . We predicted that using raised against the neural markers Tuj1 (Chemicon), GFAP (Calbiochem), or CC1 (Calbiochem) after 1, 3, 5, genetically matched EGFP transgenic donor and recipient mice would promote MSC survival after transplanta-7, and 10 days of Schwann cell coculture, respectively. tion and that greater survival would correlate with im-FACS of EGFP + MSCs From Schwann Cell Cocultures proved neurological and histopathological outcomes. We also predicted that exposing MSCs to a neural envi-After 5 days of coculture, the mixture of MSCs and Schwann cells was collected by trypsinization. The cell ronment (Schwann cells) prior to transplant might promote neural differentiation or compatibility and further suspension was washed with 3% BSA in PBS, triturated, and passed through a 40-µm cell strainer to generate a increase their therapeutic effects. We herein report that despite using genetically matched EGFP donors and recip-single cell suspension. A culture of MSCs that had not undergone coculturing and a Schwann cell culture were ients, less than 3% of MSCs survived 2 weeks posttransplant and that by 5 weeks posttransplant the number of treated with the same procedures to serve as positive and negative controls, respectively. EGFP-expressing SMSCs surviving MSCs was less than 1%. However, mice that received MSC transplants and, to a greater extent, those were isolated using FACS and collected into 100% FBS. The sorted SMSC EGFP-expressing cells were centri-that received Schwann cell cocultured MSCs (SMSCs), demonstrated improved neurological outcomes and ben-fuged at 1500 rpm for 5 min and resuspended at 10 7 cells/ml in saline prior to transplantation. eficial changes in the lesion microenvironment.
MATERIALS AND METHODS

Mouse Model of SCI and Cell Transplantation Cell Culture
All injuries were performed on adult female C57B6-Kr15-EGFP mice that express EGFP in hair follicle All protocols for these experiments were approved by the University of Western Ontario Animal Care Com-bulge cells (38) . These mice were selected to be the spinal cord-injured transplant recipients because they ex-mittee in accordance with the policies established in the Guide to Care and Use of Experimental Animals press EGFP on a C57B6 genetic background. EGFP in these mice is expressed in hair follicles and thus we rea-prepared by the Canadian Council on Animal Care. Tg(ACTBEGFP)1Osb adult male mice, which express soned that EGFP expressed by transplanted MSCs or SMSCs would not be immunogenic in these recipients. EGFP ubiquitously, were used to establish MSC cultures using the physical property of plastic adherence (15, 18) .
Using an operating microscope, an 8.3 g force clip compression injury was made at the T4 segmental level as This transgenic line of mice was selected as MSC donors because their MSCs can be traced after transplanta-described previously (29, 30, 32) . Transplantation was performed 7 days after SCI because MSC transplanta-tion by their expression of EGFP. Once cells were 80% confluent, MSCs were passaged (1:3 dilution) with fresh tion before this time has met with reduced graft survival (25). The dura was incised with the tip of an injection medium. Flow cytometry was performed using antibodies raised against a battery of markers to characterize needle exposing the surface of the injured spinal cord. MSCs (3 × 10 4 cells/3 µl), SMSCs (3 × 10 4 cells/3 µl), MSCs at passage 4, including c-kit, CD11b, CD31, CD34, CD45, and isotype controls. or saline (3 µl) were injected into the cord at the lesion site using a spinal stereotaxic frame by means of a glass Schwann cell cultures were established from C57B6 adult mice as described previously (60) , and maintained pipette (tip diameter 100 µm) configured to a 10-µl Hamilton syringe. In order to confirm that MSCs and PBS. The C7-T10 vertebral segments, which included the site of the compression injury, were removed and SMSCs were delivered successfully into the injured cord, spinal cord sections collected from a small set of processed for cryosectioning and immunohistochemistry. All sections were cut at a thickness of 16 µm. Sec-animals (n = 4 per group) 48 h posttransplantation were immunostained with an anti-EGFP antibody, and the tions spanning the injury sites were selected for analyses (Table 1) . The maximum distance rostral and caudal to signal visualized by a peroxidase-DAB reaction after a hematoxylin counterstain. A second set of animals (sa-the injury investigated for pathology was determined by the distance from the lesion at which a particular patho-line controls, MSCs, and SMSCs, n = 12 per group) underwent cardiac perfusion at 3 weeks postinjury and logical feature returned to baseline levels. The number of sections analyzed reflected the section-to-section histological analyses for MSC and SMSC survival, macrophages, Schwann cells, chondroitin sulfate proteogly-variability (the greater the variability the more sections analyzed) to avoid a sampling bias. cans (CSPGs), neurofilament, and laminin. A third set of animals (saline controls, MSCs, and SMSCs, n = 6 Immunohistochemistry per group) underwent locomotor testing for 6 weeks postinjury before cardiac perfusion and histological Slides were incubated with the appropriate dilutions of primary antibodies in a humidified chamber at 4°C analyses for MSC and SMSC survival, myelin sparing, neuronal sparing, and collagen deposition (see Fig. 1 for overnight. The list of primary and secondary antibodies used and their dilutions is provided in Eight Kr15-EGFP mice underwent SCI and then 7 days later were selected to receive either MSC or SMSC grafts (n = 4 per group). Forty-eight hours posttransplantation, all mice were sacrificed by cardiac perfusion and their spinal cord was sectioned for anti-GFP staining. (B) Thirty-six mice underwent SCI and then 7 days later were selected to receive either saline or MSC or SMSC grafts (n = 12 per group). Mice were subsequently sacrificed by cardiac perfusion and their spinal cord prepared for histological investigations as indicated. (C) Eighteen mice underwent SCI and received either saline or MSC or SMSC grafts (n = 6 per group) 7 days post-SCI. All mice were evaluated at 1, 3, 7, 10, 14, 21, 28, 35, and 42 days postinjury for locomotor recovery. Mice were subsequently sacrificed by cardiac perfusion and their spinal cord prepared for histological investigations as indicated. 
MSC and SMSC Survival After Transplantation
ues of white matter sparing were compared among three groups of animals and reported. MSC and SMSC survival was quantified using spinal cord sections collected at 14 and 35 days after transplan-Measurement of the Collagen Deposition tation, respectively. Twenty-five sections from the area Seven sections, each section separated by 160 µm, of cord 2 mm rostral and 2 mm caudal to the lesion were processed for Masson's trichrome staining (Sigma, epicenter representing one tenth of the total spinal cord St. Louis, MO). Briefly, the sections were incubated in volume in this segment were collected at a minimum of preheated Bouin's solution at 56°C for 15 min. Nuclei 32 µm apart from MSC-and SMSC-treated animals.
were stained black with Weigert's iron hematoxylin for The sections were stained with an anti-EGFP antibody, 1 min at room temperature, and cytoplasm was then and the signal visualized by a peroxidase-DAB reaction stained with Beibrich scarlet-acid fuchsin. After treatand hematoxylin counterstain. Y chromosome painting ment with phosphotungstic and phosphomolybdic acid, for engrafted MSC was also performed on adjacent seccollagen was demonstrated by staining with aniline blue. tions using fluorescent in situ hybridization (FISH).
The blue-stained area was measured using ImagePro
Assessment of Locomotor Function
Plus Software and expressed as a percentage of the cross-sectional area of the same spinal cord section. Locomotor recovery of spinal cord-injured mice was assessed by two independent observers using the 9-point Assessment of Neuronal Sparing Basso mouse scale (BMS) from 1 day to 6 weeks after NeuN-positive neurons within the lesion site were SCI (5). Testing was done once a week. Scores of the quantified 6 weeks after injury. Transverse sections left and right hind limbs were averaged. The locomotor were serially collected within 1.5 mm rostral and 1.5 analysis and all other analyses detailed below were done mm caudal to the lesion epicenters at intervals of 80 µm blinded to the treatment the mice had received (n = 6 and stained with an anti-NeuN antibody and an Alexa per group). Cumulative BMS scores were used to look Fluor 594-conjugated secondary antibody. The number for relationships between locomotor recovery and each of NeuN-expressing cells was counted using ImagePro of myelin sparing, neuronal sparing, and collagen depo-Plus software. Three continuous sections with the greatsition at the scar. Cumulative BMS scores were obtained est loss of neurons defined the position of the lesion by summing each animal's BMS score obtained over all epicenter. Six sections 80 µm apart spanning the distrials. Cumulative BMS scores have been used by others tance from the epicenter to ϳ0.5 mm rostral were (12) and avoids the problem of sample bias that may stained for NeuN expression, and the number of immuoccur if only the final scores obtained on the last trial noreactive cells averaged and normalized to the numbers are used.
of neurons from relatively intact spinal cord sections Measurement of White Matter Sparing from the same animal. A second and third set of six sections 80 µm apart were likewise evaluated for NeuN Transverse sections of spinal cord 6 weeks after injury were serially collected and mounted on glass slides. expression between 0.5-1.0 mm and 1.0-1.5 mm from the lesion epicenter. The same process was repeated for Ten sections from each cord, spanning approximately 1 mm in length across the lesion site, were stained with spinal cord regions caudal to the lesion epicenters. hematoxylin and eosin. Sections demonstrating the most Analysis of CSPG, NF200, Laminin, severe disruption of normal white and gray matter archiand p75 Immunoreactivity tecture were considered to mark the position of the lesion epicenter in that animal. Nine sections at 250-µm Immunohistochemistry to detect CSPG, neurofilament, laminin, and p75 was performed on four to six intervals were processed for solochrome cyanin staining to identify the residual blue-stained white matter be-serial-collected longitudinal sections spaced 32 µm apart from the control, MSC, and SMSC transplant recipients tween the lesion epicenter and 1.5 mm rostral and caudal to the epicenter, respectively. Ratios of the stained area 3 weeks postinjury. Immunostaining for CSPGs was done using CS56, an antibody that recognizes the termi-to the total area of the spinal cord section (per area measurements) were measured using ImagePro Plus soft-nal portions of chondroitin sulfate-4 or -6 side chains and thus detects a variety of CSPGs (3,13). For laminin ware (Media Cybernectic, Silver Spring, MD). Because of the frequent distortion of the cord by scar and the and p75 immunoreactivity, one digital image per cord was taken across the lesion site, with a 10× objective. compression at and near the lesion, white matter (per area) of sections from relatively intact cord at 2 mm
The signal intensity of CS56 and anti-NF200 immunostaining was reduced relative to that of the anti-laminin caudal to the lesion epicenter in the same animal was also quantified and used to normalize the white matter and p75 immunostaining, necessitating the use of higher magnification for microscopic examination. To quantify areas closer to the lesion. The normalized per area val-the area of immunoreactivity for CS56 and NF200, two MSCs in the spinal cord-injured female recipients. The sections were first treated with 0.2N HCl for 30 min and equal-sized digital images were taken from each cord, using a 20× objective under identical illumination and incubated with sodium thiocyanate for 30 min at 80°C. The sections were digested with 1 mg/ml proteinase K exposure settings. One image was rostral and the other caudal to the lesion epicenter. Both images represented (Invitrogen) for 45 min at 37°C and dehydrated through graded alcohols. The biotin-labeled mouse Y chromo-the highest intensity of CS56 or NF200 immunoreactivity in that area of the cord. Using the ImagePro Plus some probes were denatured at 37°C for 43 min (Cambio, Dry Drayton, UK) before applying them to the sec-software, the digital images were imported as an 8-bit grayscale image and its meninges were trimmed off to tions. The slides were denatured at 75°C for 6 min, then hybridized with the Y chromosome probe for 20 h at eliminate nonspecific labeling. The threshold for positive signal was set at 75 in the histogram (0-225), which 37°C. After hybridization, slides were washed in a 45°C water bath first in 1:1 formamide/1× SSC, then 1× SSC, eliminated background staining. The number of pixels above the threshold was calculated, averaged with those and 1× SSC + 0.05% Tween 20. After washing, the Y chromosome signal was detected with an Avidin-Texas of the same treatment group, and reported. test. Data for area of CS56, NF200, laminin, p75 immunoreactivity, and CBA assay were analyzed by a one-way Cytometric Bead Array (CBA) Assay ANOVA with a Neuman-Keuls posttest. Correlations The BD TM CBA mouse inflammation kit (BD Bioscibetween cumulative BMS scores and myelin sparing, ence) was used to quantitatively measure interleukin-6 neuronal sparing, or area of collagenous scar were calcu-(IL-6), IL-10, monocytes chemoattractant protein-1 lated using a single regression analysis. Differences (MCP-1), interferon-γ (INF-γ), tumor necrosis factor were considered statistically significant if p < 0.05. (TNF), and IL-12p70 protein levels in the supernatant collected from MSC culture, Schwann cell culture, and RESULTS after 1, 3, 5, and 7 days of MSC-Schwann cell cocul-In Vitro Differentiation of MSCs ture, respectively. The assays were performed according to the manufacturer's instruction (n = 4). Briefly, six
Five independent cultures of MSCs were isolated from the bone marrow of ACTB-EGFP transgenic adult bead populations with distinct fluorescence intensities were coated with capture antibodies specific for IL-6, male mice. Flow cytometry was used to characterize MSC cultures at passages 4-6. MSCs in culture did not IL-10, MCP-1, INF-γ, TNF, and IL-12p70 protein; PEconjugated detection antibodies and test samples were express the stem cell marker c-kit, or markers of the hematopoietic (CD34, CD45, or CD11b) or endothelial incubated together to form sandwich complexes. Standards provided with the kit were appropriately diluted (CD31) cell lineages (data not shown). The colonyforming unit-fibroblast (CFU-F) assay was used as a and used in parallel to samples for preparation of the standard curves. Each supernatant sample (25 µl) was functional method to quantify mesenchymal stem and progenitor cells in mouse bone marrow. The frequency diluted at 1:2 with the assay diluents and added to 50 µl of capture beads mixture and 50 µl of detector Ab-PE.
of fibroblast-like colonies from each mouse bone marrow sample was about 0.0008-0.0018% (n = 4). To test After incubating for 2 h at room temperature, the mixture was washed and analyzed using flow cytometry and the prediction that exposing MSCs to a neural environment prior to transplantation would increase the fre-the FCAP Assay software.
quency of MSC neural differentiation in the injured spi-Y Chromosome Painting for Engrafted MSC Detection nal cord we cocultured the EGFP-expressing MSCs with wild-type (nontransgenic) Schwann cells prior to trans-Cryostat spinal cord sections (16 µm) collected 21 days after SCI were used for detection of engrafted male plantation. Passage 4 MSCs were cultured with Schwann cells and then immunostained for EGFP expression and markers of neural differentiation after 1, 3, 5, 7, and 10 days of coculturing. A small percentage (ϳ6%) of MSC not cocultured with Schwann cells was found to express the neuronal marker Tuj1 (β-III tubulin), but not GFAP or CC1, markers of astrocytes and oligodendrocytes, respectively ( Fig. 2A-C) . Five days after coculturing with Schwann cells, 13 ± 5.6% of MSC were immune positive for β-III tubulin, 13 ± 3.5% for GFAP, and 15 ± 2.7% positive for CC1 ( Fig. 2D-F ). Five days of Schwann cell coculturing was selected as the optimum time to collect MSCs for transplantation as all three neural markers showed the highest frequency of expression at this time point ( Fig. 2G ). EGFP-expressing SMSCs were isolated from the Schwann cells to 99% purity using FACS. Schwann cells maintained their characteristic morphology and were positive for S-100 during the coculture period.
MSC Transplants Survived Only Temporarily in the Spinal Lesion
K15-EGFP mice received a clip compression injury at the fourth thoracic (T4) segment of the spinal cord. K15-EGFP mice express EGFP in hair follicle stem cells. One week after injury animals received an intraspinal injection of either saline (3 µl), or EGFP-expressing MSCs (MSCs 3 × 10 4 /3 µl) or Schwann cells cocultured EGFP-expressing MSCs (SMSCs, 3 × 10 4 /3 µl). Immunohistochemistry using anti-GFP antibody revealed a total absence of GFP-expressing cells in the injured spinal cords of K15-EGFP control mice (Fig. 3A) , demonstrating that recipient EGFP-expressing skin stem cells do not migrate to the injured spinal cord and that EGFP expression could be used to accurately track MSCs and SMSCs in mice after transplantation. Successful delivery of the MSCs and SMSCs into the lesion epicenter was verified by anti-EGFP immunostaining spinal cord sections from a subset of animals sacrificed at 48 h posttransplantation (Fig. 3B ). The engrafted cells, mostly found at or close to the lesion epicenter, displayed robust EGFP expression and demonstrated as the typical MSC spindle shape.
Three and 6 weeks post-SCI MSC and SMSC engraftment was evaluated in sections by their EGFP expression. The majority of the MSCs and SMSCs were pared to MSC-treated mice, although this difference was not maintained at later time points. 30, respectively (Fig. 3F) . To discount the possibility that MSCs and SMSCs were not detected because of SMSC Transplantation Promoted Myelin Sparing reduced transgene expression, we used Y chromosome in situ hybridization to detect the male donor cells in the Solochrome cyanine staining of histological sections female recipients. This analysis demonstrated comparaspanning 2 mm from the lesion epicenters of saline-, ble numbers of Y chromosome-positive cells and EGFP-MSC-, and SMSC-treated mice was analyzed for the expressing cells in the lesions of animals receiving the presence of white matter 6 weeks postinjury. The area of MSC grafts and that, where present, they coincided spawhite matter per section was measured using ImagePro tially in directly adjacent serial sections (Fig. 3G, H) .
software to quantify the amount of blue-stained myelin. This analysis revealed increased myelin sparing in MSC and SMSC Transplantation Improved SMSC-treated mice (group × distance from the lesion, Locomotor Recovery p = 0.008). In control and treatment groups the injury resulted in almost complete loss of the white matter at The 8.3 g clip compression injury was severe and in the epicenter (Fig. 5A-C) . Near the lesion center, at all mice caused a flaccid paralysis and little or no hind 0.25 mm rostral and caudal to the epicenter, myelin was limb movement during the first week postinjury. Saline, detected in small patches that constituted a small per-MSCs, or SMSCs (Schwann cells were removed by cell centage of the normalized cross-sectional area of the sorting prior to injection) was administered 7 days postcord in both control and treated mice. At 0.5 mm ( Fig  injury. Locomotor recovery in the saline-treated mice 5D-I) and 0.75 mm (Fig. 5J ) rostral and caudal to the was marginal with animals in this group reaching a maxepicenter, SMSC-treated mice had substantially more imum BMS score of 1 ± 0.47, indicating that these anivisible myelin, compared to MSC-treated mice and samals were only capable of slight ankle movement 6 line control mice ( Fig. 5D-I) . At 1 mm from the injury weeks postinjury (Fig. 4) . MSC-treated mice achieved a site, the tissue retained much of its normal structure, and maximum BMS score of 1.9 ± 0.53, indicating extensive thus no significant difference in the amount of myelin ankle movement. SMSC-treated mice recovered extenstaining was found between control and treated groups sive ankle movement and many in this group also demthis distance from the lesion epicenter ( Fig. 5J ). Linear onstrated plantar placement (average BMS score of 2.5 ± regression analysis revealed a significant correlation be-0.83). Chi-square analysis revealed a higher observed tween cumulative BMS scores and myelin sparing 0.5 frequency of plantar placement (4/6) in the SMSC group mm from the lesion epicenter (r 2 = 0.84) ( Fig. 5K ). versus saline controls (0/6) 6 weeks postinjury (χ 2 = 6.0, p < 0.02). Repeated measures ANOVA revealed im-SMSC and MSC Transplantation Promoted proved locomotor recovery in MSC-and SMSC-treated Neuronal Sparing mice as indicated by the significant group × time interaction (p = 0.004). Locomotor improvements were sta-Immunohistochemistry using an anti-NeuN antibody on histological sections spanning 3 mm centered on the tistically significant between SMSC-and saline-treated mice as early as 3 weeks postinjury and between MSC-lesion epicenters of saline-, MSC-, and SMSC-treated mice was used to assess neuronal sparing. The lesion and saline-treated mice by 4 weeks postinjury. At 3 epicenter, which extended about 0.5 mm, had a complete SMSC Transplantation Significantly Reduced the Collagen Deposition at the Lesion Site loss of neurons in both ventral and dorsal horns. Neuronal survival adjacent to the lesion was significantly improved in SMSC-treated mice compared to either The histopathological response in mice following SCI is characterized by secondary lesion sites that are MSC-treated mice or saline controls (group × distance from lesion, p < 0.0001). At 0.5 mm rostral to the lesion filled with macrophages and fibroblasts embedded in a well-vascularized collagenous stroma (27, 37) . The col-center, 32 ± 4.8% of neurons survived in SMSC-treated mice, compared to 22 ± 7.2% in MSC-treated mice and lagenous scar has been implicated as an obstacle to axonal regeneration in brain and spinal cord injury (22, 48) . 26 ± 5.8% in saline controls ( Fig. 6A-C) . At 1.0 mm rostral, 80 ± 4.1% of neurons survived in SMSC-treated At 6 weeks after SCI, Masson's trichrome staining demonstrated significant decreases in collagen deposition mice, while only 55 ± 10.6% of neurons survived in MSC-treated and 55 ± 7.0% in saline-treated mice (Fig.  (blue) in the injured spinal cord of SMSC-treated mice (group × distance from lesion, p = 0.04). At the epicen-6D-F). At 1.5 mm rostral and caudal to the lesion epicenters neuronal loss was minimal in the all groups ter of SMSC-treated mice 31 ± 6.7% of the spinal cord cross-sectional area was occupied by collagen compared (neuronal survival rate >90%) ( Fig. 6G-J) . Caudal to the lesions a statistically significant increase in neuronal to 42 ± 8.7% and 40 ± 10.9% in MSC-and saline-treated mice, respectively ( Fig. 7A-C) . At 0.16 mm rostral and survival was evident in SMSC-treated mice at 1.0 mm from the lesion epicenter and in both MSC-and SMSC-caudal to the epicenter, about 20% of the spinal cord cross-sectional area was occupied by collagen in SMSC-treated mice relative to saline controls at 0.5 mm caudal to the lesion epicenter ( Fig. 6J) . Linear regression analy-treated mice, compared to 30% in MSC-and salinetreated mice (Fig. 7D-I) . At 0.5 mm rostral and caudal sis showed significant correlation between cumulative BMS scores and neuronal sparing 1.0 mm from the le-to the lesion epicenters, the amount of collagen deposition became minimal (<10%) in treated and control sion epicenter (r 2 = 0.80) (Fig. 6K ). (Fig. 7J ). Linear regression analyses indicated an boundary of the lesion epicenters with virtually no 5-HT immunoreactivity observed in the epicenters of the sa-inverse correlation between cumulative BMS scores and collagen staining at 0.16 mm from the lesion epicenter line control group and MSC-treated group. However 5-HT-positive fibers were found along the subpial rim of (r 2 = 0.43) (Fig. 7K) .
the cord, on the lateral edge of MSC-and SMSC-treated MSC and SMSC Transplantation Decreases CSPG lesions (Fig. 9E, F) , as well as in the lesion epicenters and Increases Laminin in the Scar in SMSC-treated mice (Fig. 9F) . 5-HT-positive fibers were also distributed caudal to the lesion in MSC-and The absence of axonal regeneration after SCI has been attributed, in part, to axon-repelling CSPGs in the SMSC-treated mice (Fig. 9H, I) . 5-HT-positive fibers were not seen at the subpial rim or in the regions caudal scar produced in response to the injury (13) . However, some components of the scar, namely laminin and fibro-to the lesion in saline controls. nectin, promote axonal growth (10, 14, 51, 55) . Thus, we
SMSCs Led to Robust Recruitment of Endogenous evaluated CSPG and laminin expression in the lesions
Schwann Cells Into the Injury Site of treated and untreated mice 3 weeks postinjury using an antibody, CS56, that recognizes many different MSCs transplanted into the injured spinal cord have been shown to increase Schwann cell infiltration of the CSPGs (3,13) and an anti-laminin antibody. The 3-week postinjury time point was chosen for this analysis be-injury sites (24, 35, 36) . We evaluated Schwann cell infiltration of the injury sites in saline controls and MSC-cause BMS scores begin to improve at this time. In all groups, the intensity of CSPG immunoreactivity was and SMSC-treated mice using immunohistochemistry and an anti-p75 antibody. Schwann cells were present in most pronounced in the penumbra adjacent to the lesion epicenter ( Fig. 8A-C) . The area of CSPG immunoreac-the injured spinal cords in all three groups. The area of p75 immunoreactivity was used to assess the relative tivity was substantially reduced in MSC-and SMSCtreated mice compared to saline controls (Fig. 8A-D) .
numbers of Schwann cells in the lesions of saline controls and MSC-and SMSC-treated mice. This analysis MSC-treated mice showed an increase in the area of laminin immunoreactivity surrounding the lesion rela-revealed that a greater number of Schwann cells infiltrated the lesions in SMSC-treated animals compared to tive to controls, and SMSC-treated mice showed increased laminin expression surrounding the lesion com-MSC-treated animals or controls ( Fig. 10A-D) . Double immunostaining with anti-p75 antibodies and antibodies pared to both MSC-treated mice and controls ( Fig.  8E-H) .
raised against the peripheral myelin marker P0 demonstrated that some Schwann cells produced myelin and The reductions in collagen and CSPG and increase in laminin expression in MSC-and SMSC-treated mice led may have participated in axon remyelination (Fig. 10E ). Since Schwann cells have been shown to produce lami-to the prediction that MSC-and SMSC-treated mice would demonstrate greater amounts of axonal growth in nin in the injured spinal cord and the MSC-and SMSCtreated mice demonstrated higher levels of both Schwann their lesions than saline controls. To test this prediction we performed immunohistochemistry on sections through cell infiltration and laminin immunoreactivity in their lesions, we immunostained serial sections with anti-p75 the lesion epicenters in all three groups of mice using an anti-neurofilament (NF200) antibody. The area of and anti-laminin antibodies to investigate the spatial distribution of laminin relative to the Schwann cell popula-NF200 immunoreacitivity was increased in the penumbra in MSC-and SMSC-treated mice (Fig. 8I-L) . There tion. The spatial overlap of the anti-p75 and anti-laminin immunohistochemistry suggests that Schwann cells may was a near total absence of NF2000 immunostaining in the epicenter of the lesion in saline-and MSC-treated be a source of laminin in these lesions ( Fig. 10F-H) . mice, whereas NF200 staining was present in the core MSC/SMSC Transplantation Decreases the Number of the lesion in SMSC-treated mice (Fig. 8, insets i-k) .
of
Mac-1-Positive Macrophages at the Lesion Identification of Serotonergic Axons Caudal
The reported immunomodulatory effects of MSC to the Lesion After MSC or SMSC Treatment transplants (39, 53) and the altered scar deposition in our SMSC-treated mice led us to evaluate the macrophage Descending serotonergic (5-HT-positive) axons provide excitatory input to motor neurons and the loss of population in the lesions in the treated and untreated mice. We used Mac-1 antibody to immunostain macro-these inputs has been correlated to locomotor dysfunction (44) . We evaluated serotonergic fiber density in lon-phages and microglia in the injured spinal cord 3 weeks after injury. The majority of Mac-1-positive cells were gitudinal sections spanning the lesion epicenters in saline controls and MSC-and SMSC-treated mice 3 weeks found at or near the injury epicenter and decreased distally ( Fig. 11A-F) . The density of Mac-1 + cells was after SCI. In all groups of mice, a dense accumulation of 5-HT-positive axons occurred rostral to the lesion (Fig. much lower in MSC-treated (2526 ± 471/mm 3 ) or SMSC-treated animals (2011 ± 295/mm 3 ) compared to 9A-D). 5-HT immunoreactivity ceased abruptly at the NF200 immunoreactivity was increased in the penumbra of MSC-treated (J) and SMSC-treated (K) mice compared to saline controls. (i-k) Insets demonstrate near total absence of NF200-labeled axons in the epicenter of the lesion in saline controls (i), and increased NF200-labeled axons in MSC-treated (j) and SMSC-treated mice (k). (D) The area of CS56 immunoreactivity was substantially reduced across the lesion in MSC-treated mice compared to saline controls. CS56 immunoreactivity was also reduced in SMSC-treated mice compared to both saline controls and MSC-treated mice. (H, L) The areas of laminin and NF200 immunoreactivity were increased in MSC-and SMSC-treated mice compared to saline controls. *Statistically significant difference, p < 0.05 (n = 4 for saline group; n = 5 for MSC and SMSC groups). Scale bars: 50 µm. saline controls (5442 ± 532/mm 3 ) at the lesion epicen-Schwann cultures, and Schwann cell-MSC cocultures after 1, 3, 5, and 7 days, using the mouse inflammation ters (group × distance from the lesion, p < 0.0001). There were also far fewer Mac-1 + cells 0.5 mm rostral CBA assay. Standard curves from 0 to 2500 pg/ml for each cytokine were generated according to the manufac-and caudal to the lesion epicenters in MSC-and SMSCtreated mice compared to saline controls (Fig. 11G) .
turer's recommendations and used to calculate the level of each cytokine in the conditioned media ( Fig. 12A , Schwann Cell Coculturing Alters MSC B). Only IL-6 and MCP-1 were detectable in MSC and Chemokine Production Schwann cell culture medium (Fig. 12C, D) . A significant decrease in both IL-6 and MCP-1 were demon-The greater reduction in macrophages at the lesions strated in the Schwann cell-MSC cocultures at all time of SMSC-treated compared to MSC-treated mice sugpoints evaluated (Fig. 12E, F) . gested that the SMSCs and MSCs may differ in their chemokine or cytokine expression profiles. To measure DISCUSSION the release of cytokines/chemokines by MSCs, before and after coculturing with Schwann cells, we measured
We hypothesized that by matching donor and recipient mice for genetic background and MSC maker gene IL-6, IL-10, MCP-1, INF-γ, TNF, and IL-12p70 protein levels in conditioned media from MSC cultures, expression (EGFP) we would maximize MSC survival were only capable of slight ankle movement 6 weeks postinjury. SMSC-treated mice demonstrated far better One explanation may be that in those studies cells were injected into, or took up residence in, the developing recovery with most animals in this group showing plantar placement by 6 weeks postinjury (average BMS cyst that forms in the injured rat spinal cord (1, 35, 36, 54, 58, 59) . The cyst may create a microenvironment score of 2.5 ± 0.83). The small number of surviving transplanted cells suggests that cell replacement was not that protects MSC from inflammation or it may provide a confined space that allows MSC-produced growth fac-the mechanism through which MSCs and SMSCs improved outcomes in mice after SCI. Since MSC are tors to reach critical levels to support their own survival. Mouse spinal cords do not develop large cystic cavities known to have anti-inflammatory effects (39, 53) , we evaluated the possibility that the improved neurological after injury as do rats (7,28), and MSC survival is poor in the rat when transplants are performed early after in-outcomes could be attributed to increased neuroprotection or altered scar deposition in mice receiving MSC jury, before a cyst may develop (56) . grafts. White matter sparing was increased in SMSC-that correlated with the observed changes in matrix deposition were assessed by neurofilament immunoreactiv-treated mice and neuronal sparing was increased in both MSC-and SMSC-treated mice. Wound healing, scar-ity. Both MSC-and SMSC-treated mice had greater amounts of neurofilament staining in the penumbra ros-ring, and matrix deposition are ongoing processes that are also linked to the inflammatory response (20) . The tral and caudal to the lesion. SMSC-treated mice also had increased amounts of neurofilament staining in their treated mice had less collagen scar as well as less CSPG and more laminin expression in their lesions. The lesion epicenters. This evidence of increased structural plasticity around and within the lesion epicenters could amount of collagen scarring correlated negatively with locomotor recovery, as expected, given the well-known account for the improved locomotor scores in MSC-and SMSC-treated mice as it confirms that the lesions in detrimental effects of scarring on axonal plasticity and regeneration. The decreased CSPG and increased lami-these mice permit or promote axon sprouting from spared axons that may underlie new circuitry transmit-nin levels in treated mice led to the prediction that axonal growth might be increased in these animals (4,6, ting supraspinal input past the lesion sites. In the severe injury model used in this study one might expect that 16, 26, 55) . Changes in axonal growth around the lesion recovery might be more dependent on local circuitry as the absence of 5-HT staining in saline controls. Thus, increased BMS scores in treated mice may be due to opposed to descending supraspinal inputs. Improvements in the lesion microenvironment that promote axon combination of increased structural plasticity at the lesion and increased spared supraspinal serotoneregic in-sprouting might facilitate the formation of these circuits and or their function. It may be telling to note that the puts. The MSC and SMSC treatments also changed the cel-reports of improved locomotion in spinal cord-injured animals receiving MSC transplants tend to be those that lular component of the lesion microenvironment. In particular, lesions in both MSC-and SMSC-treated mice use more severe injuries (25,41,56) as opposed to less severe ones (1,36).
had fewer Mac-1 + macrophages and more Schwann cells in their lesion epicenters than saline controls. The trans-The improved locomotor function in the treated mice could also be explained by increased sparing of supra-plants may reduce the infiltration and activation of both the monocyte-derived macrophages and resident microg-spinal inputs that synapse below the level of the lesion. To investigate the possibility that spared supraspinal in-lia. However, since monocyte-derived macrophages predominate at the lesion epicenter and their infiltration puts may contribute to the locomotor recovery in these mice, we stained sections for 5-HT immunoreactivity as peaks between 7 and 14 days after SCI in C57B6 mice (33) , it is most likely that the MSCs and SMSCs reduced supraspinal serotonergic inputs to the ventral horn are critical to motor function after SCI (44) . The strong 5-the number of monocyte-derived macrophages at the injury site. The decreased number of macrophages in the HT immunoreactivity at, and caudal to, the lesion epicenters in mice receiving MSC transplants contrasts with lesions of treated mice may account for some of the in- crease in white matter sparing observed, as others have topathological evidence of neuroprotection, and changes in the lesion microenvironment that can enhance recov-reported increased white matter sparing after SCI by strategies that lower neutrophil and macrophage infiltra-ery and regeneration. We suggest that coculturing MSCs with Schwann cells likely enhances their immunosup-tion (19, 43, 45) . The increased number of Schwann cells drawn into the lesions of mice that received MSC grafts pressive effects and that these cells thereby alter the cascade of destructive events that normally occur as a con-may have contributed to the increase in laminin in these lesions as Schwann cells express laminin (31) and the sequence of SCI resulting in greater neuroprotection and changes in the molecular and cellular make-up of the distribution of laminin correlates spatially with the Schwann cell distribution in these mice. In addition to lesion microenvironment. This effect may be due to one or several factors produced by the transplanted cells. the production of laminin, increased Schwann cells in the treated mice may account for other improvements in Since SMSCs outperform MSCs on every histopathological index of recovery, an investigation of differences in recovery as Schwann cells may be a source of growth factors in the injured cord (36) and both endogenous gene expression profiles in MSCs and SMSCs should identify key molecular determinants that direct the heal-Schwann cells and transplanted Schwann cells have been shown to improve recovery after SCI (23, 49) .
ing process after SCI toward a more favorable outcome. SCI triggers innate and adaptive immune responses ACKNOWLEDGMENTS: This work was supported in part by that exacerbate the injury and increase tissue loss (2).
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Given the known suppressive effects of MSCs on innate 
